Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials-Reference-Cited by-同舟云学术

Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials

Published:2014-02-27 Issue:11 Volume:120 Page:1713-1724
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Meza Rafael¹,ten Haaf Kevin²,Kong Chung Yin³⁴,Erdogan Ayca⁵,Black William C.⁶,Tammemagi Martin C.⁷,Choi Sung Eun³⁴,Jeon Jihyoun⁸,Han Summer S.⁵,Munshi Vidit³⁴,van Rosmalen Joost²⁹,Pinsky Paul¹⁰,McMahon Pamela M.³⁴,de Koning Harry J.²,Feuer Eric J.¹¹,Hazelton William D.⁸,Plevritis Sylvia K.⁵

Affiliation:

1. Department of Epidemiology; University of Michigan; Ann Arbor Michigan

2. Department of Public Health; Erasmus University Medical Center; Rotterdam the Netherlands

3. Institute for Technology Assessment; Massachusetts General Hospital; Boston Massachusetts

4. Department of Radiology; Harvard Medical School; Boston Massachusetts

5. Department of Radiology; Stanford University; Stanford California

6. Department of Radiology, Geisel School of Medicine at Dartmouth; Dartmouth College; Hanover New Hampshire

7. Department of Community Health Sciences; Brock University; St. Catharines Ontario Canada

8. Program in Biostatistics and Biomathematics, Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle Washington

9. Department of Biostatistics; Erasmus University Medical Center; Rotterdam the Netherlands

10. Division of Cancer Prevention; National Cancer Institute; Bethesda Maryland

11. Division of Cancer Control and Population Sciences; National Cancer Institute; Bethesda Maryland

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med.,2011

2. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial;Oken;JAMA.,2011

3. Benefits and harms of CT screening for lung cancer: a systematic review;Bach;JAMA.,2012

4. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening;Bach;Ann Intern Med.,2012

5. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000;Moolgavkar;J Natl Cancer Inst.,2012

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study;eClinicalMedicine;2024-08

2. Lung cancer screening: where do we stand?;Breathe;2024-06

3. The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations;Medical Decision Making;2024-05-13

4. The Benefits and Harms of Lung Cancer Screening in Individuals With Comorbidities;JTO Clinical and Research Reports;2024-03

5. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening;JAMA Network Open;2023-11-22